As of 2025-07-14, the EV/EBITDA ratio of Intercept Pharmaceuticals Inc (ICPT) is -22.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICPT's latest enterprise value is 915.51 mil USD. ICPT's TTM EBITDA according to its financial statements is -40.56 mil USD. Dividing these 2 quantities gives us the above ICPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 14.2x | 11.4x |
| Forward P/E multiples | 12.7x - 19.7x | 14.2x |
| Fair Price | (15.18) - (16.69) | (15.34) |
| Upside | -179.9% - -187.9% | -180.7% |
| Date | EV/EBITDA |